FMO2 alleviates doxorubicin-induced cardiac injury via promoting XLF-dependent DNA repair

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Basic bombshells in heart failure Cardiotoxicity of Drugs and Other Therapies ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by